Loading...
XJPX
3649
Market cap130mUSD
Oct 09, Last price  
866.00JPY
1D
2.73%
1Q
-3.99%
Jan 2017
-8.65%
IPO
939.24%
Name

Findex Inc

Chart & performance

D1W1MN
XJPX:3649 chart
P/E
16.82
P/S
3.46
EPS
51.50
Div yield, %
2.61%
Shrs. gr., 5y
-0.39%
Rev. gr., 5y
8.82%
Revenues
6.11b
+4.60%
668,501,000772,034,0001,144,771,0001,543,160,0001,987,789,0002,382,635,0002,863,916,0002,951,922,0003,288,025,0003,311,714,0003,603,344,0004,281,538,9994,004,859,0004,968,885,0004,541,242,0005,191,735,0005,841,379,0006,109,941,000
Net income
1.26b
+8.14%
91,647,00084,893,000193,087,000221,961,000431,877,000517,836,000630,071,000441,399,000499,915,000366,628,000398,015,000499,249,000430,457,000636,026,000722,779,0001,059,140,0001,162,364,0001,256,971,000
CFO
1.65b
-12.97%
102,123,000116,549,000269,617,000171,847,000550,567,000556,521,0001,281,728,000126,961,0001,137,233,000580,488,000597,524,0001,670,010,000542,550,000750,353,000693,848,000842,844,0001,898,767,0001,652,441,000
Dividend
Dec 29, 202614 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

FINDEX Inc., a company established in Tokyo in 1985, focuses on the creation, production, and distribution of medical technology systems across Japan. Their portfolio features Claio, a comprehensive medical imaging database management system utilized by hospitals of all sizes, and C-Note, a dedicated platform for managing patient progress notes. They also offer DocuMaker, a sophisticated document and data management solution engineered with various input tools to boost efficiency, and the GAP/GAP-screener, which is an advanced gaze analyzing perimeter. Additionally, FINDEX Inc. develops mobile applications for smartphones. Their services cater to a wide range of medical clients, including hospitals, clinics, and other healthcare institutions. The organization adopted its current name, FINDEX Inc., in November 2014, having previously operated as PSC Inc.

Key people

Teruo Aibara
President, Manager of Business Strategy Office, Representative Director · since 1994
Atsushi Fujita
Executive Officer, Director of Administration · since 2023
Hideaki Mochizuki
Executive Officer, Director of Planning and Development · since 2023
Takashi Murakami
Executive Officer · since 2023
Hiroaki Hasegawa
Director of Consulting, Director · since 2023
Keisuke Kakiuchi
Director of Hospital Solution, Director · since 2025
Koji Kondo
Director of Medical Solution, Director · since 2008
Riki Miyakawa
Manager of Security Office, Director · since 2025
Koji Yamauchi
Director · since 2016
Takahiro Yazawa
Director · since 2026
Takashi Kitada
Independent Director · since 2016
Kyoko Matsuba
Independent Director · since 2026
Akira Ono
Independent Director · since 2022
Akira Yamada
Independent Director · since 2021
Akane Yui
Independent Director · since 2026
IPO date
Mar 23, 2011
Employees
282
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT